How long does it usually take to see the effects of vorasidenib-VORANIGO?

Vorasidenib (trade name: VORANIGO) is an oral selective IDH1/IDH2 inhibitor, mainly used to treat patients with relapsed or refractory glioma carrying IDH1 or IDH2 mutations. The drug inhibits the activity of mutant isocitrate dehydrogenase (IDH) and reduces the accumulation of 2-hydroxyglutarate (2-HG) in tumors, thereby inhibiting tumor growth and improving the cell metabolic environment.

Normally, Voxanib needs to be taken continuously for a period of time before the therapeutic effect can be observed. Clinical studies have shown that most patients begin to experience improvements in imaging and biomarkers around 3 months, including reduction or stabilization of tumor volume and a decrease in 2-HG levels. The time for the efficacy to appear is affected by many factors such as the patient's tumor load, mutation type, previous treatment, and individual metabolic differences, so the specific time may vary.

At the beginning of taking the medicine, the patient may not feel immediate improvement in symptoms, which is a normal reaction of the drug’s mechanism of action. Vorsidenib improves the tumor microenvironment by gradually inhibiting mutant IDH enzymes and related metabolic abnormalities. Therefore, continuous and regular medication is the key to observing the efficacy. At the same time, MRI or other imaging examinations need to be performed regularly to evaluate tumor changes, and the biological effects of the drug are monitored through the levels of 2-HG in the blood or cerebrospinal fluid.

In general, the efficacy of VORANIGO (VORANIGO) usually gradually appears after approximately 3 months of continuous medication, but complete stabilization or significant tumor shrinkage may take longer. During use, patients should strictly follow the doctor's instructions to take the medicine, and regularly review tumor indicators and laboratory indicators in order to timely evaluate the efficacy and adjust the treatment plan. Adhering to standardized medication and scientific follow-up is an important guarantee for ensuring the therapeutic effect and safety of vorsidenib.

Reference link:https://www.drugs.com